Literature DB >> 21937448

The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.

Petr Dmitriev1, Andrei Petrov, Eugenie Ansseau, Luiza Stankevicins, Sébastien Charron, Elena Kim, Tomas Jan Bos, Thomas Robert, Ahmed Turki, Frédérique Coppée, Alexandra Belayew, Vladimir Lazar, Gilles Carnac, Dalila Laoudj, Marc Lipinski, Yegor S Vassetzky.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD), a dominant hereditary disease with a prevalence of 7 per 100,000 individuals, is associated with a partial deletion in the subtelomeric D4Z4 repeat array on chromosome 4q. The D4Z4 repeat contains a strong transcriptional enhancer that activates promoters of several FSHD-related genes. We report here that the enhancer within the D4Z4 repeat binds the Krüppel-like factor KLF15. KLF15 was found to be up-regulated during myogenic differentiation induced by serum starvation or by overexpression of the myogenic differentiation factor MYOD. When overexpressed, KLF15 activated the D4Z4 enhancer and led to overexpression of DUX4c (Double homeobox 4, centromeric) and FRG2 (FSHD region gene 2) genes, whereas its silencing caused inactivation of the D4Z4 enhancer. In immortalized human myoblasts, the D4Z4 enhancer was activated by the myogenic factor MYOD, an effect that was abolished upon KLF15 silencing or when the KLF15-binding sites within the D4Z4 enhancer were mutated, indicating that the myogenesis-related activation of the D4Z4 enhancer was mediated by KLF15. KLF15 and several myogenesis-related factors were found to be expressed at higher levels in myoblasts, myotubes, and muscle biopsies from FSHD patients than in healthy controls. We propose that KLF15 serves as a molecular link between myogenic factors and the activity of the D4Z4 enhancer, and it thus contributes to the overexpression of the DUX4c and FRG2 genes during normal myogenic differentiation and in FSHD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937448      PMCID: PMC3247939          DOI: 10.1074/jbc.M111.254052

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Krüppel-like factor, a novel zinc finger repressor.

Authors:  S Uchida; Y Tanaka; H Ito; F Saitoh-Ohara; J Inazawa; K K Yokoyama; S Sasaki; F Marumo
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  A unifying genetic model for facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Rinse Klooster; Sabrina Sacconi; Pilar Camaño; Johannes G Dauwerse; Lauren Snider; Kirsten R Straasheijm; Gert Jan van Ommen; George W Padberg; Daniel G Miller; Stephen J Tapscott; Rabi Tawil; Rune R Frants; Silvère M van der Maarel
Journal:  Science       Date:  2010-08-19       Impact factor: 47.728

4.  Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.

Authors:  R J Osborne; S Welle; S L Venance; C A Thornton; R Tawil
Journal:  Neurology       Date:  2006-12-06       Impact factor: 9.910

5.  DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation.

Authors:  Darko Bosnakovski; Sarah Lamb; Tugba Simsek; Zhaohui Xu; Alexandra Belayew; Rita Perlingeiro; Michael Kyba
Journal:  Exp Neurol       Date:  2008-08-06       Impact factor: 5.330

6.  Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level.

Authors:  Rinse Klooster; Kirsten Straasheijm; Bharati Shah; Janet Sowden; Rune Frants; Charles Thornton; Rabi Tawil; Silvère van der Maarel
Journal:  Eur J Hum Genet       Date:  2009-10-07       Impact factor: 4.246

7.  Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity.

Authors:  Joost J Leenders; Wino J Wijnen; Monika Hiller; Ingeborg van der Made; Viola Lentink; Rick E W van Leeuwen; Veronica Herias; Saraswati Pokharel; Stephane Heymans; Leon J de Windt; Morten A Høydal; Yigal M Pinto; Esther E Creemers
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

8.  Characterization of the human gene encoding the scavenger receptor expressed by endothelial cell and its regulation by a novel transcription factor, endothelial zinc finger protein-2.

Authors:  Hideki Adachi; Masafumi Tsujimoto
Journal:  J Biol Chem       Date:  2002-04-26       Impact factor: 5.157

9.  Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.

Authors:  Marietta Barro; Gilles Carnac; Sébastien Flavier; Jacques Mercier; Yegor Vassetzky; Dalila Laoudj-Chenivesse
Journal:  J Cell Mol Med       Date:  2008-05-24       Impact factor: 5.310

10.  Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle.

Authors:  Davide Gabellini; Michael R Green; Rossella Tupler
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

View more
  13 in total

1.  A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function.

Authors:  Sachiko Homma; Jennifer C J Chen; Fedik Rahimov; Mary Lou Beermann; Kendal Hanger; Genila M Bibat; Kathryn R Wagner; Louis M Kunkel; Charles P Emerson; Jeffrey Boone Miller
Journal:  Eur J Hum Genet       Date:  2011-11-23       Impact factor: 4.246

2.  Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression.

Authors:  Beverly A Teicher; Eric Polley; Mark Kunkel; David Evans; Thomas Silvers; Rene Delosh; Julie Laudeman; Chad Ogle; Russell Reinhart; Michael Selby; John Connelly; Erik Harris; Anne Monks; Joel Morris
Journal:  Mol Cancer Ther       Date:  2015-09-08       Impact factor: 6.261

3.  Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.

Authors:  Petr Dmitriev; Luiza Stankevicins; Eugenie Ansseau; Andrei Petrov; Ana Barat; Philippe Dessen; Thomas Robert; Ahmed Turki; Vladimir Lazar; Emmanuel Labourer; Alexandra Belayew; Gilles Carnac; Dalila Laoudj-Chenivesse; Marc Lipinski; Yegor S Vassetzky
Journal:  J Biol Chem       Date:  2013-10-20       Impact factor: 5.157

4.  Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.

Authors:  Charis L Himeda; Céline Debarnot; Sachiko Homma; Mary Lou Beermann; Jeffrey B Miller; Peter L Jones; Takako I Jones
Journal:  Mol Cell Biol       Date:  2014-03-17       Impact factor: 4.272

5.  The glucocorticoid receptor and KLF15 regulate gene expression dynamics and integrate signals through feed-forward circuitry.

Authors:  Sarah K Sasse; Christina M Mailloux; Andrea J Barczak; Qian Wang; Mohammed O Altonsy; Mukesh K Jain; Saptarsi M Haldar; Anthony N Gerber
Journal:  Mol Cell Biol       Date:  2013-03-18       Impact factor: 4.272

6.  Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.

Authors:  Gregory J Block; Lisa M Petek; Divya Narayanan; Amanda M Amell; James M Moore; Natalia A Rabaia; Ashlee Tyler; Silvere M van der Maarel; Rabi Tawil; Galina N Filippova; Daniel G Miller
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

Review 7.  Novel excitation-contraction coupling related genes reveal aspects of muscle weakness beyond atrophy-new hopes for treatment of musculoskeletal diseases.

Authors:  Heather Manring; Eduardo Abreu; Leticia Brotto; Noah Weisleder; Marco Brotto
Journal:  Front Physiol       Date:  2014-02-18       Impact factor: 4.566

8.  DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy.

Authors:  Peter E Thijssen; Judit Balog; Zizhen Yao; Tan Phát Pham; Rabi Tawil; Stephen J Tapscott; Silvère M Van der Maarel
Journal:  Skelet Muscle       Date:  2014-10-24       Impact factor: 4.912

9.  Cancer-related genes in the transcription signature of facioscapulohumeral dystrophy myoblasts and myotubes.

Authors:  Petr Dmitriev; Ulykbek Kairov; Thomas Robert; Ana Barat; Vladimir Lazar; Gilles Carnac; Dalila Laoudj-Chenivesse; Yegor S Vassetzky
Journal:  J Cell Mol Med       Date:  2013-12-17       Impact factor: 5.310

10.  DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?

Authors:  Alexandra Tassin; Dalila Laoudj-Chenivesse; Céline Vanderplanck; Marietta Barro; Sébastien Charron; Eugénie Ansseau; Yi-Wen Chen; Jacques Mercier; Frédérique Coppée; Alexandra Belayew
Journal:  J Cell Mol Med       Date:  2012-12-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.